Posts filled under #sapphirecoast

Good morning from Twofold

Good morning from Twofold Bay in the @sapphirecoastnsw You'll find this lovely lookout in Eden, which is a small town on @visitnsw's far south coast. According to local @s_chenhall, there are plenty of excellent spots here to "snuggle up and watch life on the bay", which also happens to be the third deepest natural harbour in the southern hemisphere. This particular vantage point overlooks both headlands and is just a short distance from the cafes and shops of Eden's main street. #sapphirecoast #newsouthwales #travel #explore #sunrise

Need a new challenge?

Need a new challenge? Winter swimming perhaps? Each Sunday morning the Bermagui Blue Ball's meet here, at Bermagui Blue Pool for a dip and they love welcoming new people. Image: @davey_rogers #winterswimming #bermagui #sapphirecoast #ilovensw

Even after seeing so many

Even after seeing so many of the famous Aussie sea stacks, this one will always be my favourite, loved being here again last week, simply magic . Oh I should also put a in here to @tjzphoto and @canningmartin who shared the spot with me on this evening! . . . #focusaustralia #exploringaustralia #horseheadrock #sapphirecoast #iphoneography #aussiephotos #adventure #aussie_images #australiagram #seeaustralia #instagood #ig_shotz #bermagui #wanderaustralia #travel #ig_australia #unlimited_australia #wanderlust #earthfocus #sky_sultans #ig_discover_australia #australia_shotz #awesomeearth #beautifuldestinations #earthpix #wow_australia2017 #australia_oz #aussiephotos_aug17 #stephseyeview

An extract on #sapphirecoast

In 1993 the ATF, FBI, and Texas National Guard raided one of their properties for suspected weapons violations. Once the Branch Davidians met the raid with gunfire they were laid siege for 51 days. The siege ended with a raid which resulted in the deaths of the Branch Davidians' leader, David Koresh, as well as 82 other Branch Davidian men, women, and children, and four ATF agents.

Because of their effectiveness, tolerability, and rapid onset of anxiolytic action, benzodiazepines are frequently used for the treatment of anxiety associated with panic disorder. However, there is disagreement among expert bodies regarding the long-term use of benzodiazepines for panic disorder. The views range from those that hold that benzodiazepines are not effective long-term and that they should be reserved for treatment-resistant cases to that they are as effective in the long term as selective serotonin reuptake inhibitors. The American Psychiatric Association (APA) guidelines note that, in general, benzodiazepines are well tolerated, and their use for the initial treatment for panic disorder is strongly supported by numerous controlled trials. APA states that there is insufficient evidence to recommend any of the established panic disorder treatments over another. The choice of treatment between benzodiazepines, SSRIs, serotoninnorepinephrine reuptake inhibitors, tricyclic antidepressants, and psychotherapy should be based on the patient's history, preference, and other individual characteristics. Selective serotonin reuptake inhibitors are likely to be the best choice of pharmacotherapy for many patients with panic disorder, but benzodiazepines are also often used, and some studies suggest that these medications are still used with greater frequency than the SSRIs. One advantage of benzodiazepines is that they alleviate the anxiety symptoms much faster than antidepressants, and therefore may be preferred in patients for whom rapid symptom control is critical. However, this advantage is offset by the possibility of developing benzodiazepine dependence. APA does not recommend benzodiazepines for persons with depressive symptoms or a recent history of substance abuse. The APA guidelines state that, in general, pharmacotherapy of panic disorder should be continued for at least a year, and that clinical experience support continuing benzodiazepine treatment to prevent recurrence. Although major concerns about benzodiazepine tolerance and withdrawal have been raised, there is no evidence for significant dose escalation in patients using benzodiazepines long-term. For many such patients stable doses of benzodiazepines retain their efficacy over several years. Guidelines issued by the UK-based National Institute for Health and Clinical Excellence (NICE), carried out a systematic review using different methodology and came to a different conclusion. They questioned the accuracy of studies that were not placebo-controlled. And, based on the findings of placebo-controlled studies, they do not recommend use of benzodiazepines beyond two to four weeks, as tolerance and physical dependence develop rapidly, with withdrawal symptoms including rebound anxiety occurring after six weeks or more of use. Nevertheless, benzodiazepines are still prescribed for long-term treatment of anxiety disorders, although specific antidepressants and psychological therapies are recommended as the first-line treatment options with the anticonvulsant drug pregabalin indicated as a second- or third-line treatment and suitable for long-term use. NICE stated that long-term use of benzodiazepines for panic disorder with or without agoraphobia is an unlicensed indication, does not have long-term efficacy, and is, therefore, not recommended by clinical guidelines. Psychological therapies such as cognitive behavioural therapy are recommended as a first-line therapy for panic disorder; benzodiazepine use has been found to interfere with therapeutic gains from these therapies. Benzodiazepines are usually administered orally; however, very occasionally lorazepam or diazepam may be given intravenously for the treatment of panic attacks.